Founded | 1946 | as Damon Runyon Cancer Memorial Fund
---|---|
Founder | Walter Winchell |
Focus | "We fund high-risk, high-reward cancer research. We identify and enable young scientists who are brilliant, brave and bold enough to go where others haven't." [1] |
Location |
|
Area served | United States |
Method | Cancer research [1] |
Key people | Yung S. Lie, PhD, president and chief executive officer |
Revenue | $15,978,604 [2] |
Employees | 16 [3] |
Website | damonrunyon.org |
The Damon Runyon Cancer Research Foundation (Damon Runyon) is an American not-for-profit cancer research organization focused on "discovering the talent to discover the cure". [1] The organization states that its goals are to: "identify the best and brightest early career scientists in cancer research, accelerate the translation of scientific discoveries into new diagnostic tools and treatments, and to enable risk-taking on bold new ideas". [1]
The organization was founded in 1946 by media personality Walter Winchell in New York City, New York, under the name Damon Runyon Cancer Memorial Fund in memory of his colleague and friend Damon Runyon, a newspaperman and author.
Almost immediately after Runyon's passing on December 10, 1946, Winchell went on the air and asked his audience for contributions to cancer research: [4]
Mr. and Mrs. United States! A very dear friend of mine – a great newspaperman, a great writer, and a very great guy – Damon Runyon, was killed this week by America's Number Two killer – Cancer. It's time we tried to do something to fight this terrible disease. We must fight back, and together we can do it. Won't you send me a penny, a nickel, a dime, or a dollar? All of your money will go directly to the cancer fighters, in Damon Runyon's name. There will be no expenses of any kind deducted.
The organization gained more visibility in 1949 when Milton Berle, a long-time friend of both Runyon and Winchell, hosted the first-ever telethon, raising $1.1 million for the foundation over 16 hours. [5] [6] In its first three decades, the foundation was a popular cause among celebrities from Hollywood to Broadway and the sports world. Marlene Dietrich, Bob Hope, Marilyn Monroe, Joe DiMaggio, and many of their contemporaries served as supporters and board members. [7]
The organization manages six award programs "aimed at encouraging and advancing the work of early career cancer researchers with high promise". The Fellowship Award is the oldest and most widely known in the scientific community, giving postdoctoral researchers between $200,000 and $250,000 over four years. [8] Other programs include the Damon Runyon-Sohn Pediatric Cancer Fellowship Award, the Damon Runyon Clinical Investigator Award and the Damon Runyon-Rachleff Innovation Award. The foundation launched in 2020 the Damon Runyon Quantitative Biology Fellowship to bridge quantitative approaches to cancer research. [9]
The foundation has funded twelve Nobel Prize laureates, including Albert Szent-Györgyi, Salvador E. Luria, Susumu Tonegawa and Sidney Altman. [10] Sixty-five foundation scientists and alumni have been elected to the U.S. National Academy of Sciences.
Charity Navigator rates the foundation four of four stars, indicating the organization "exceeds industry standards and outperforms most charities in its Cause". [11] According to the Better Business Bureau, the foundation met the twenty standards for charity accountability as of 2011. [12] A timeline listing of specific accomplishments and milestones by foundation scientists is available on the foundation's website. [13]
Alfred Damon Runyon was an American newspaperman and short-story writer.
Walter Winchell was a syndicated American newspaper gossip columnist and radio news commentator. Originally a vaudeville performer, Winchell began his newspaper career as a Broadway reporter, critic and columnist for New York tabloids. He rose to national celebrity in the 1930s with Hearst newspaper chain syndication and a popular radio program. He was known for an innovative style of gossipy staccato news briefs, jokes and Jazz Age slang. Biographer Neal Gabler credited his popularity and influence meant “He turned journalism into a form of entertainment.”
A telethon is a televised fundraising event that lasts many hours or even days, the purpose of which is to raise money for a charitable, political or other purportedly worthy cause.
The American Cancer Society (ACS) is a nationwide voluntary health organization dedicated to eliminating cancer. Established in 1913, the society is organized into six geographical regions of both medical and lay volunteers operating in more than 250 Regional offices throughout the United States. Its global headquarters is located in the American Cancer Society Center in Atlanta, Georgia. The ACS publishes the journals Cancer, CA: A Cancer Journal for Clinicians and Cancer Cytopathology.
Susan G. Komen is a breast cancer organization in the United States.
The St. Baldrick's Foundation is a not-for-profit organization with the aim of raising funds to help find cures for children with cancer. The name of the foundation is not associated with a recognized Saint of the Catholic Church, but is founded on word play and appropriation of the title of sainthood. Volunteers sponsored by family, friends, and employers shave their heads or "chop" their ponytails in solidarity with children who typically lose their hair during cancer treatment in order to raise funds.
The National Psoriasis Foundation (NPF) is the world's largest nonprofit organization serving people with psoriasis and psoriatic arthritis. The NPF provides information and services to help people manage their condition, while supporting research to find a cure. In addition to serving more than 3 million people annually through patient and professional health education and advocacy initiatives, the NPF has funded more than $10 million in psoriatic disease research grants and fellowships.
The Jane Coffin Childs Memorial Fund for Medical Research, established in 1937, awards the "Jane Coffin Childs Postdoctoral Fellowship" for research in the medical and related sciences bearing on cancer.
Wilma K. Olson is the Mary I. Bunting professor at the Rutgers Center for Quantitative Biology (CQB) at Rutgers University. Olson has her own research group on the New Brunswick campus. Although she is a polymer chemist by training, her research aims to understand the influence of chemical architecture on the conformation, properties, and interactions of nucleic acids.
The Helen Hay Whitney Foundation, established in New York in 1943 by Joan Whitney Payson in cooperation with the estate planning of her mother, Helen Hay Whitney (1875–1944), awards the "Helen Hay Whitney Postdoctoral Fellowship" for support postdoctoral research in the biomedical sciences.
The Prevent Cancer Foundation (PCF) is a United States-based charity, and one of the leading US health organizations devoted to the early detection and prevention of cancer.
Andrew D. Luster is the Persis, Cyrus and Marlow B. Harrison Professor of Medicine at Harvard Medical School, and the Chief of the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital. He is Director of its Research Center for Immunology and Inflammatory Diseases, and a member of the Dana-Farber/Harvard Cancer Center's Cancer Immunology program.
Ovarian Cancer Research Alliance (OCRA) is a not-for-profit organization focused on ovarian cancer research, advocacy and patient support. The organization was formed in January 2016 when the former not-for-profit organization Ovarian Cancer Research Fund, which focused primarily on ovarian cancer research, combined with Ovarian Cancer National Alliance, which focused primarily on ovarian cancer advocacy and support programs, to form one organization.
William G. Kaelin Jr. is an American Nobel Laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana-Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.
Nathanael S. Gray is a professor of biological chemistry and molecular pharmacology at Harvard Medical School and professor of cancer biology at Dana-Farber Cancer Institute. His work focuses on synthetic chemistry and novel small molecule inhibitors.
Emily P. Balskus is an American chemical biologist, enzymologist, microbiologist, and biochemist born in Cincinnati, Ohio in 1980. She has been on the faculty of the Chemistry and Chemical Biology department of Harvard University since 2011 and is currently the Morris Kahn Associate Professor. She has published more than 80 peer-reviewed papers and three book chapters. Since 2012 she has been invited to give over 170 lectures, has held positions on various editorial boards, and served as a reviewer for ACS and Nature journals among others. Balskus also currently serves as a consultant for Novartis, Kintai Therapeutics, and Merck & Co.
Rafael Fonseca is a Mexican-American physician and researcher. He is the Getz Family Professor of Medicine and Chair of the Department of Internal Medicine at the Mayo Clinic in Arizona.
Helen Jane Dyson is a British-born biophysicist and a professor of integrative structural and computational biology at the Scripps Research Institute in La Jolla, California. She is also currently editor-in-chief of the Biophysical Journal.
Myung Kyungjae is a biologist researching DNA repair pathways at the molecular level. He is a Distinguished Professor at the Ulsan National Institute of Science and Technology (UNIST) and the Director of the IBS Center for Genomic Integrity located on the UNIST campus. He is on the editorial board of various peer-reviewed journals and is a member of multiple scientific societies.
Susan Kaech is an American immunologist. Kaech is a professor and director of the NOMIS Center for Immunobiology and Microbial Pathogenesis at the Salk Institute for Biological Sciences. She holds the NOMIS Foundation Chair. Her research focuses on the formation of memory T cells, T cell metabolism, and cancer immunotherapy.